Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sumatriptan: update and review.

Roger Cady1, Curtis Schreiber

  • 1Headache Care Center, 3805 S. Kansas Expressway, Springfield, MO 65804, USA.

Expert Opinion on Pharmacotherapy
|July 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world use of lecanemab: patient pathway findings from a US multicenter study.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Sumatriptan, a leading migraine medication, effectively treats migraines and cluster headaches. It improves quality of life and reduces lost work productivity.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Sumatriptan was the first triptan medication approved for migraine treatment.
  • Several other triptans have since been approved, but sumatriptan remains widely prescribed.

Purpose of the Study:

  • To review the efficacy, safety, and impact of sumatriptan in migraine and cluster headache treatment.
  • To highlight sumatriptan's role in advancing migraine understanding and patient treatment paradigms.

Main Methods:

  • Review of clinical studies and pharmacoeconomic research on sumatriptan.
  • Analysis of sumatriptan's effectiveness in treating migraine with or without aura and cluster headaches.

Main Results:

  • Sumatriptan is effective and well-tolerated for migraine and is the only triptan approved for cluster headaches.

Related Experiment Videos

  • Studies show sumatriptan enables earlier treatment, reduces disability, and improves quality of life.

    • Conclusions:

    • Sumatriptan has been pivotal in establishing a biological basis for migraine.
    • Its established safety profile and proven effectiveness continue to make it a cornerstone therapy for migraine and cluster headaches.